Small Molecule p38 MAP Kinase Inhibitors for the Treatment of Inflammatory Diseases: Novel Structures and Developments During 2006-2008

被引：71

作者：

Pettus, Liping H. ^{[1
]}

Wurz, Ryan P. ^{[1
]}

机构：

[1] Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA

来源：

CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2008年 / 8卷 / 16期

关键词：

D O I：

10.2174/156802608786264245

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The p38 mitogen-activated protein (MAP) kinase plays a central role in inflammation. It has been the subject of extensive efforts in both basic research and drug discovery for the treatment of inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis, where aberrant cytokine signaling is the driver of the disease. This article reviews the patent and journal publication activities during 2006-2008 describing novel small molecule p38 alpha inhibitors.

引用

页码：1452 / 1467

页数：16

共 50 条

[21] Novel Lead Structures for p38 MAP Kinase via FieldScreen Virtual Screening
Cheeseright, Timothy J.
Holm, Melanie
Lehmann, Frank
Luik, Sabine
Gottert, Marcia
Melville, James L.
Laufer, Stefan
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (14) : 4200 - 4209
[22] A Frozen Analogue Approach to Aminopyridinylimidazoles Leading to Novel and Promising p38 MAP Kinase Inhibitors
Selig, Roland
Goettert, Marcia
Schattel, Verena
Schollmeyer, Dieter
Albrech, Wolfgang
Laufer, Stefan
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (19) : 8429 - 8439
[23] Identification of novel p38α MAP kinase inhibitors using fragment-based lead generation
Gill, AL
Frederickson, M
Cleasby, A
Woodhead, SJ
Carr, MG
Woodhead, AJ
Walker, MT
Congreve, MS
Devine, LA
Tisi, D
O'Reilly, M
Seavers, LCA
Davis, DJ
Curry, J
Anthony, R
Padova, A
Murray, CW
Carr, RAE
Jhoti, H
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) : 414 - 426
[24] Trimethylsilylpyrazoles as novel inhibitors of p38 MAP kinase: A new use of silicon bioisosteres in medicinal chemistry
Barnes, Matthew J.
Conroy, Richard
Miller, David J.
Mills, John S.
Montana, John G.
Pooni, Parminder K.
Showell, Graham A.
Walsh, Louise M.
Warneck, Julie B. H.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (02) : 354 - 357
[25] Design, synthesis and biological evaluations of novel substituted imidazooxazoles as potent p38 MAP kinase inhibitors
Liu, YB
Ashwell, MA
Ali, SM
Antonenko, V
Graceffa, R
Harris, M
Kaselj, M
Kelleher, E
Liu, J
O'Donnell, M
Selliah, R
Tandon, M
Vensel, D
Wrona, W
Lapierre, JM
Bresciano, K
Caserta, K
Chan, H
Gannett, T
Jones, S
Leydon, P
Mcdonald, S
Naper, A
Saraswat, L
Tyler, A
Warren, M
Zhu, S
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2723 - U2723
[26] SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 map kinase inhibitors
Revesz, L
Di Padova, FE
Buhl, T
Feifel, R
Gram, H
Hiestand, P
Manning, U
Zimmerlin, AG
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (11) : 1261 - 1264
[27] p-38, map-kinase: An exciting target for the treatment of inflammatory diseases.
Dominguez, C
Liu, LB
Zhang, DW
Tamayo, N
Powers, D
Min, W
Feige, F
Harris, R
Wild, S
Neervannan, S
Rashid, S
Harvey, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U941 - U942
[28] P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis
Kimberly K Brown
Sandra A Heitmeyer
Erin B Hookfin
Lily Hsieh
Maria Buchalova
Yetunde O Taiwo
Michael J Janusz
Journal of Inflammation, 5
[29] P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis
Brown, Kimberly K.
Heitmeyer, Sandra A.
Hookfin, Erin B.
Hsieh, Lily
Buchalova, Maria
Taiwo, Yetunde O.
Janusz, Michael J.
JOURNAL OF INFLAMMATION-LONDON, 2008, 5 (1):
[30] Small molecule p38 inhibitors: Novel structural features and advances from 2002-2005
Hynes, J
Leftheris, K
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (10) : 967 - 985

← 1 2 3 4 5 →